Related references
Note: Only part of the references are listed.Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC
Amy C. Moreno et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage NSCLC
Eric D. Brooks et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
Willemijn S M E Theelen et al.
Lancet Respiratory Medicine (2020)
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial
David Ball et al.
LANCET ONCOLOGY (2019)
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer A Phase 2 Clinical Trial
David A. Palma et al.
JAMA ONCOLOGY (2019)
Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?
Eric D. Brooks et al.
FRONTIERS IN ONCOLOGY (2019)
Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer
William A. Stokes et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy
Jordan A. Krall et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer Findings From the NRG Oncology RTOG 0618 Trial
Robert D. Timmerman et al.
JAMA ONCOLOGY (2018)
Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
Eric D. Brooks et al.
JAMA NETWORK OPEN (2018)
Toward Precision Radiotherapy for Use with Immune Checkpoint Blockers
Claire Vanpouille-Box et al.
CLINICAL CANCER RESEARCH (2018)
Multi-Institutional Experience of Stereotactic Body Radiotherapy for Large (≥5 Centimeters) Non-Small Cell Lung Tumors
Vivek Verma et al.
CANCER (2017)
7-Year Follow-Up After Stereotactic Ablative Radiotherapy for Patients With Stage I Non-Small Cell Lung Cancer: Results of a Phase 2 Clinical Trial
Bing Sun et al.
CANCER (2017)
Stereotactic Body Radiotherapy for Large (> 5 cm) Non-Small-Cell Lung Cancer
Justin Peterson et al.
CLINICAL LUNG CANCER (2017)
Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy
Lina Zhao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer
Joshua E. Rosen et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2016)
Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with Ultracentral Non-Small Cell Lung Cancer
Hilal Tekatli et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
Michael B. Bernstein et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Parametric regression model for survival data: Weibull regression model as an example
Zhongheng Zhang
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403
Yasushi Nagata et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non-Small-Cell Lung Cancer What We Have Learned
Joe Y. Chang et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
Joe Y. Chang et al.
LANCET ONCOLOGY (2015)
Stage Migration in Planning PET/CT Scans in Patients Due to Receive Radiotherapy for Non-Small-Cell Lung Cancer
Geoffrey A. Geiger et al.
CLINICAL LUNG CANCER (2014)
Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases
Nicholas Stephens et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2014)
Management of Mediastinal Relapse after Treatment with Stereotactic Body Radiotherapy or Accelerated Hypofractionated Radiotherapy for Stage I/II Non-Small-Cell Lung Cancer
Jeremy M. Kilburn et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study
Peter C. Austin et al.
STATISTICS IN MEDICINE (2007)
Share Paper
